Table 1.
Enzyme | Method | Beta cell type |
|||||
---|---|---|---|---|---|---|---|
INS-1 | INS-1E | INS-1 832/13 | r-islets | m-islets | Authors [reference no.] | ||
PC | Silencing | – | – | Jensen et al. [36] | |||
Silencing | ↓ | Hasan et al. [34] | |||||
Silencing | ↓ | ↓ | Xu et al. [35] | ||||
Overproduction | ↑ | Xu et al. [35] | |||||
Enzyme inhibition | ↓ | Liu et al. [37] | |||||
Enzyme inhibition | ↓ | Farfari et al. [40] | |||||
PDH | Overproduction PDK4 | – | Xu et al. [35] | ||||
mGPDH | KO | – | Eto et al. [19] | ||||
KO | – | Brown et al. [26] | |||||
cME | Silencing | ↓ | Pongratz et al. [42] | ||||
Silencing | ↓ | Guay et al. [43] | |||||
Silencing | – | Brown et al. [48] | |||||
Silencing | ↓ | – | Ronnebaum et al. [44] | ||||
Silencing | ↓ | Xu et al. [45] | |||||
KO | – | Ronnebaum et al. [44] | |||||
mME | Silencing | – | Pongratz et al. [42] | ||||
Silencing | ↓ | – | Ronnebaum et al. [44] | ||||
Silencing | – | Brown et al. [48] | |||||
ACL | Silencing | ↓ | Guay et al. [43] | ||||
Silencing | – | MacDonald et al. [60] | |||||
Silencing | – | – | Joseph et al. [53] | ||||
ACC1 | Silencing | ↓ | Ronnebaum et al. [59] | ||||
Enzyme inhibition | ↓ | ↓ | MacDonald et al. [52] | ||||
FAS | Silencing | – | – | Joseph et al. [53] | |||
Enzyme inhibition | ↓ | ↓ | MacDonald et al. [52] | ||||
ICD | Silencing | ↓ | ↓ | Ronnebaum et al. [62] | |||
CIC | Silencing | ↓ | ↓ | Joseph et al. [61] | |||
ATP-SCS | Silencing | – | – | Kibbey et al. [63] | |||
GTP-SCS | Silencing | ↓ | ↓ | Kibbey et al. [63] | |||
PEPCK-M | Silencing | ↓ | Stark et al. [65] | ||||
GDH | Overproduction | ↑ | ↑ | ↑ | Carobbio et al. [69] | ||
Gain of function mutant | – | Tanizawa et al. [73] | |||||
Beta cell KO | Partial reduction | Carobbio et al. [77] | |||||
GC1 | Silencing | Partial reduction | Casimir et al. [78] |
↑ increased; ↓ decreased; – not changed; ATP-SCS, ATP-dependent succinyl-CoA synthetase; CIC, citrate/isocitrate carrier; GC1, glutamate carrier 1; ICD, NADP-dependent isocitrate dehydrogenase; KO, knockout